These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35164998)

  • 1. MiR-155 inhibits TP53INP1 expression leading to enhanced glycolysis of psoriatic mesenchymal stem cells.
    Liu Y; Zhao X; Li J; Zhou L; Chang W; Li J; Hou R; Li J; Yin G; Li X; Zhang K
    J Dermatol Sci; 2022 Mar; 105(3):142-151. PubMed ID: 35164998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-125b mimic inhibits ischemia reperfusion-induced neuroinflammation and aberrant p53 apoptotic signalling activation through targeting TP53INP1.
    Li XQ; Yu Q; Tan WF; Zhang ZL; Ma H
    Brain Behav Immun; 2018 Nov; 74():154-165. PubMed ID: 30193876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming.
    Nguyen PNN; Choo KB; Huang CJ; Sugii S; Cheong SK; Kamarul T
    Stem Cell Res Ther; 2017 Sep; 8(1):214. PubMed ID: 28962647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Curcumin targeting miR-155-5p/TP53INP1 axis induced oxidative stress to regulate salivary gland tumor cell proliferation and apoptosis].
    DU HL; He DQ; Wang JL; Che YF; Yan QH
    Shanghai Kou Qiang Yi Xue; 2022 Oct; 31(5):483-490. PubMed ID: 36758595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-155 acts as an oncogene by targeting the tumor protein 53-induced nuclear protein 1 in esophageal squamous cell carcinoma.
    Zhang J; Cheng C; Yuan X; He JT; Pan QH; Sun FY
    Int J Clin Exp Pathol; 2014; 7(2):602-10. PubMed ID: 24551280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-15a-5p down-regulation inhibits cervical cancer by targeting TP53INP1 in vitro.
    Zhao XQ; Tang H; Yang J; Gu XY; Wang SM; Ding Y
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8219-8229. PubMed ID: 31646552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
    Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
    Wei Q; Li YX; Liu M; Li X; Tang H
    IUBMB Life; 2012 Aug; 64(8):697-704. PubMed ID: 22730212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155-5p regulates the Th1/Th2 cytokines expression and the apoptosis of group 2 innate lymphoid cells via targeting TP53INP1 in allergic rhinitis.
    Zhu Y; Ye F; Fu Y; Zhu X; Wang Z; Wu S; Guo L; Zhang Q; Mou X; Liu Y
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108317. PubMed ID: 34731784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1.
    Zhang CM; Zhao J; Deng HY
    J Biomed Sci; 2013 Oct; 20(1):79. PubMed ID: 24152184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-504 promotes tumour growth and metastasis in human osteosarcoma by targeting TP53INP1.
    Cai Q; Zeng S; Dai X; Wu J; Ma W
    Oncol Rep; 2017 Nov; 38(5):2993-3000. PubMed ID: 29048685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p.
    Ren XY; Han YD; Lin Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4822-4835. PubMed ID: 32432745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG15 Knockdown Protects Against OGD/R-Induced Neuron Injury by Downregulating TP53INP1 Expression via Binding to miR-455-3p.
    Fan Y; Wei L; Zhang S; Song X; Yang J; He X; Zheng X
    Neurochem Res; 2021 Apr; 46(4):1019-1030. PubMed ID: 33528807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.
    Liu F; Kong X; Lv L; Gao J
    Cancer Lett; 2015 Apr; 359(2):288-98. PubMed ID: 25633840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
    Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
    Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells.
    Zhang C; Zhao J; Deng H
    Mol Cell Biochem; 2013 Jul; 379(1-2):201-11. PubMed ID: 23568502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miR-155-5p promotes proliferation and migration of gastric cancer cells by inhibiting TP53INP1 expression.
    Shi SS; Zhang HP; Yang CQ; Li LN; Shen Y; Zhang YQ
    Pathol Res Pract; 2020 Jun; 216(6):152986. PubMed ID: 32527448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A self-amplifying loop of TP53INP1 and P53 drives oxidative stress-induced apoptosis of bone marrow mesenchymal stem cells.
    Li F; Zhang F; Wang T; Xie Z; Luo H; Dong W; Zhang J; Ren C; Peng W
    Apoptosis; 2024 Jun; 29(5-6):882-897. PubMed ID: 38491252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive feedback loop of p53/miR-19/TP53INP1 modulates pancreatic cancer cell proliferation and apoptosis.
    Wang X; Wang L; Mo Q; Jia A; Dong Y; Wang G
    Oncol Rep; 2016 Jan; 35(1):518-23. PubMed ID: 26531836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo.
    Jiang F; Liu T; He Y; Yan Q; Chen X; Wang H; Wan X
    BMC Cancer; 2011 Oct; 11():425. PubMed ID: 21970405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.